Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

NACompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DEVICE

4mm x 32G pen needle

For 3 weeks, subjects used this pen needle with their own pen device for all daily insulin injections they usually administered themselves with a pen device. Subjects followed their usual insulin regimen and there was no upper limit on total daily insulin dosage or number of injections. Subjects were advised to inject straight in when using the 4mm PN, with no pinch up.

DEVICE

8mm x 31G pen needle

For 3 weeks, subjects used this pen needle with their own pen device for all daily insulin injections they usually administered themselves with a pen device. Subjects followed their usual insulin regimen and there was no upper limit on total daily insulin dosage or number of injections. Subjects were directed to use pinch-up when injecting in the abdomen or thigh with the 8mm PN, and no pinch-up at other injection sites.

DEVICE

5mm x 31G pen needle

For 3 weeks, subjects used this pen needle with their own pen device for all daily insulin injections they usually administered themselves with a pen device. Subjects followed their usual insulin regimen and there was no upper limit on total daily insulin dosage or number of injections. Subjects were advised to inject straight in when using the 5mm PN, with no pinch up.

Trial Locations (4)

30309

Atlanta Diabetes Associates, Atlanta

35209

Radiant Research, Birmingham

92026

AMCR Institute, Inc., Escondido

98057

Rainier Clinical Research Center, Inc., Renton

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY